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Background: Accumulation of excess body fat increases breast cancer risk after menopause. Whether the localized
breast is differently influenced by adipose tissue compared to the rest of the body, has not been well studied. Our
purpose was to demonstrate feasibility and preliminarily evaluate serum-based and localized breast biomarker
changes resulting from a weight loss intervention among obese postmenopausal women.
Methods: We conducted a 12-week pilot controlled dietary and exercise intervention among healthy obese
postmenopausal women, collected serum and breast ductal fluid before and after the intervention, and estimated
the association with systemic and localized biomarker changes. We recruited 7 obese (mean body mass index =
33.6 kg/m2) postmenopausal women. We collected samples at baseline and the 12th week for: anthropometry;
phlebotomy; dual-energy x-ray absorptiometry (lean and fat mass); exercise fitness (maximum oxygen consumption
(VO2Max); 1-repetition strength maximum); and breast ductal lavage.
Results: Changes from baseline occurred in body composition and exercise performance including fat mass loss
(14% average drop), VO2Max (+36% increase) and strength improvement (+26%). Breast ductal fluid markers
declined from baseline with estradiol showing a 24% reduction and IL-6 a 20% reduction. We also observed
serum biomarker reductions from baseline including leptin (36% decline), estrone sulfate (−10%), estradiol (−25%),
and Il-6 (−33%).
Conclusions: Conduct of the diet and exercise intervention, collection of ductal fluid, and measurement of
hormones and cytokines contained in the ductal fluid were all feasible. We preliminarily demonstrated estradiol and
IL-6 reductions from baseline in both serum and breast ductal fluid among obese postmenopausal women who
participated in the 12-week weight loss diet and exercise intervention.
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The rising obesity prevalence and resulting increase in
adipose tissue derived factors provide a strong rationale
for developing effective weight-loss interventions. The
majority of diet and exercise interventions designed
for breast cancer prevention are targeted toward sys-
temic parameters. However evidence suggests that the* Correspondence: ccarpenter@mednet.ucla.edu
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reproduction in any medium, provided the orlocalized breast environment may be exposed to higher
levels of adipose-derived hormones, cytokines, and in-
flammatory factors [1].
Most invasive breast cancers originate in terminal duct
lobular units consisting of ducts that travel from the
openings located on the nipple-areola complex into the
breast parenchyma [2]. While hormones during each
menstrual cycle affect proliferation of ductal cells and
their differentiation [3], after menopause there is an in-
volution of the ducts and alveoli in the breast [4]. Sur-
rounding fibrous connective tissue change in density
and breast tissues are replaced by adipose tissue. Fluidral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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lactating breast ducts and can be non-invasively
obtained from nipple aspiration and ductal lavage proce-
dures [5]. Ductal fluid has been shown in early studies
to contain hormones, growth factors, environmental
contaminants, and dietary metabolites [6-9].
Adulthood weight gain and obesity increase breast
cancer risk after menopause [10-13]. Several possible
mechanisms link body fat to breast cancer risk including
oxidative stress [14], inflammation from abdominally
distributed body fat [15,16], and excess estrogen produc-
tion [17]. These mechanisms can function locally de-
pending on the distribution of body fat and systemically
in terms of body fat production of hormones and cyto-
kines that travel in plasma.
The breast environment can be the recipient of both
serum-based and locally derived hormones and inflam-
matory cytokines. Fat tissue surrounding the stroma and
ductal epithelium, for instance, has particularly high
levels of aromatase enzyme activity [18,19]. Enhanced
localized aromatase activity coupled with estradiol levels
in the circulating plasma can potentially deliver a more
potent dose of estradiol to the localized breast than the
rest of the body.
Localized breast measurements may be critical to
evaluating risk reduction strategies. Diet and exercise
has been shown in multiple studies to protectively im-
pact serum-based estrogen, inflammation and oxidative
stress biomarkers [20-23]; however, sparse data exists for
more localized effects on the breast. Collection of breast
ductal fluid could provide a medium of localized con-
centration of risk and preventive biomarkers such as
dietary micronutrients, cytokines, and hormones found
in the breast. Several recent studies detected inflamma-
tory cytokines, markers of oxidative stress, and hor-
mones in nipple aspirate, breast milk, and breast ductal
fluid [24-28].
In order to establish feasibility and preliminarily esti-
mate the association between the controlled feeding and
exercise intervention on serum-based and localized
breast biomarkers, we conducted a 12-week pilot study
among obese sedentary postmenopausal women. We
drew blood samples to measure systemic hormonal and
cytokine markers, collected breast ductal fluid before
and after the intervention, and evaluated change in
breast biomarkers contained in the ductal fluid.
Methods
Study design and recruitment
A single 12-week intervention was conducted among
obese sedentary postmenopausal women recruited from
two sources: research staff working at UCLA and the
Love/Avon Army of Women. Eligibility criteria included
not having had menses for two or more years, age lessthan 75 years old, being sedentary (undergoing less than
1 hour per week of moderate or vigorous intensity recre-
ational exercise), and having a body-mass-index (BMI)
between 25.0 kg/m2 and 35 kg/m2. We excluded women
who could not physically undergo the exercise interven-
tion, women currently on a weight loss program, women
who ever had weight reduction surgery, or women con-
suming more than 3 servings of fruits and vegetables per
day (to eliminate participants likely to consume healthy
diets). We set an upper BMI limit of 35.0 kg/m2 to en-
sure women would not be too heavy to undergo the ex-
ercise intervention.
We utilized two sources of subjects: UCLA staff mem-
bers and the Love/Avon Army of Women. We posted
flyers around the UCLA campus inviting eligible women
to participate, and a call was put out to the Army of
Women (see reference #29) in early 2009 [29]. A total of
50 women were interested in participating (25 from
UCLA and 25 from the Love/Avon Army of Women),
and all were screened over the telephone. Of the 50
women, 13 were ineligible, 3 changed their minds, and
26 were not able to fully participate. Five women from
UCLA and 3 women from the Love/Avon Army of
Women were enrolled. One participant later dropped
midway into the study because of transportation difficul-
ties. Seven women in total completed the study. The In-
stitutional Review Board of the University of California
at Los Angeles in accordance with assurances filed with
and approved by the U.S. Department of Health and
Human Services, approved the study, and participants
provided written informed consent.
Baseline and post intervention assessments
We conducted blood sampling, breast fluid collection,
exercise testing, and anthropometry measurements in
the week prior to starting the study. Once the last base-
line measurement was made, patients were started the
next day. We scheduled measurements to occur over a
consecutive three-day period, with fasting hormone
blood levels and anthropometric measurements taken
on one day, exercise testing on another day, and ductal
lavage procedures on the third day. Order of measure-
ment days was random for each subject. Once the order
of measurements was established at baseline, the same
order was repeated at the end of the intervention,
thereby minimizing influence of measurement order on
the results. At the 12th week, measurements taken at
baseline were repeated.
Body composition was assessed using the body-mass
index measure (BMI), DEXA (dual energy x-ray absorpti-
ometry) scanning, and Bioelectrical Impedance Analysis
(BIA). BMI measurement included height assessment
with a stadiometer and weight (mass) with a calibrated
beam scale. To provide accurate measures of total
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tioned supine on the DEXA scanning table (DEXA, GE
Lunar Prodigy W Advance 2006). The same licensed tech-
nician performed all scans. Bioelectrical impedance ana-
lysis (310e Bioimpedance Analyzer; Biodynamics, Inc,
Seattle, WA) assessed BMR (basal metabolic rate) used
to estimate baseline caloric intake for the dietary
intervention.
Exercise testing
An aerobic fitness assessment determined maximum
oxygen consumption at baseline and at the end of the
intervention. The maximum oxygen consumption (VO2
max) value was used to provide an intensity starting
point for the aerobic exercise 12-week program under-
taken for each of the participants. A maximum strength
assessment determined strength at baseline and was
used similarly to determine starting level for the resist-
ance training regimen.
Testing for aerobic fitness
The VMax EncoreW, Palm Springs, CA, designed to
measure O2 and CO2 volumes utilized at rest and during
exercise, monitored a 12-lead EKG, heart rate, and gas-
eous inhalation and exhalation. The graded exercise tol-
erance test was conducted with electrocardiogram
monitoring to exclude individuals with subjective or ob-
jective evidence of coronary artery disease. The partici-
pants were sedentary. Therefore we started fitness
assessment at the lowest exercise intensity ramp, and
calibrated response to the ramp, with all subjects tested
at baseline using the lowest ramp. The speed of the bi-
cycle increased at one-minute intervals and continued
increasing until subjects could no longer continue. The
level at which they could no longer continue was mea-
sured by O2 consumption (VO2Max). All participants
improved their fitness level sufficiently to ‘graduate’ to a
higher ramp, and therefore we increased the ramp at the
end of the intervention.
Testing for muscular strength
The ‘gold standard’ of dynamic strength testing is the 1-
repetition maximum (1-RM). The 1-RM is the heaviest
weight that can be lifted only once, using good form
[30]. We conducted 1-Rep Maximum strength testing
using the Brzycki formula [31] on calibrated air displace-
ment weight equipment from KeiserW. The 1-Rep Max-
imum values were derived separately for the major
muscle groups using a variety of weight machines that
included Seated Leg Extension; Seated Chest Press;
Seated Biceps Curl; Seated Triceps Pushdown; Seated
Machine Row; Machine Squat; Seated Leg Press; and
Hamstring Curl. Testing for 1-RM involved progressivelyincreasing weight tension until participants reached their
maximum exertion point.Ductal lavage
Ductal lavage involves the infusion of small amounts of
sterile saline into a breast duct through a microcatheter
where saline is infused into the duct and then the ductal
effluent including the saline is collected. The procedure
is commonly used to collect breast epithelial cells but
can also be used to measure the endocrine microenvir-
onment of the breast [28].
Ductal lavage was attempted immediately after nipple
aspiration. Subjects were placed in the supine position.
Skin in the nipple area was cleansed with 70% alcohol,
and a fenestrated sterile drape was placed over the nip-
ple. Ductal orifices were enlarged with dilators to facili-
tate cannulation. A separate microcatheter (available
from Susan Love Foundation) was used for each duct
cannulation to prevent cross-contamination between dif-
ferent individual ductal systems. After the microcatheter
was inserted to a maximum depth of 1.5 cm, approxi-
mately 2 to 6 mL of normal saline was infused, and the
breast compressed to facilitate recovery of ductal fluid
into the collection chamber. This lavage procedure (infu-
sion, compression and effluent collection) is repeated
multiple times, instilling an average total volume of ap-
proximately 10 to 30 mL of normal saline and recover-
ing approximately 5 to 20 mL of ductal effluent per
duct. The exact infusion and effluent volumes was deter-
mined by weight to be used in the final calculations of
the analytes. Location of each fluid-yielding duct and
each cannulated duct was carefully marked on a 64-
square nipple grid. The recovered ductal effluent was
placed into tubes individually labeled for each cannu-
lated duct. The effluent was spun at 3,000 rev for 10 min-
utes, the fluid transferred to aliquots, and frozen in a
-80°C freezer.
We carefully recorded the breast we sampled and
described the duct we cannulated at baseline, using
the grid originally developed by Sartorius et al.
(1977), so that we could return to the same duct at
the 12th week of the intervention [5]. We limited our
sampling to one duct per breast, and re-sampled the
same duct from the same breast at the end of the
intervention.Blood specimen collection
Blood was drawn into tubes after a 12 hour fast. We col-
lected serum in tubes without heparin, and plasma and
buffy coat in tubes with heparin. Serum, plasma and
buffy coat were transferred to aliquots and frozen in a
−80°C freezer.
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The study sample was small and all samples, both pre
intervention and post intervention, were analyzed in the
same batch. Serum leptin was determined by enzyme
linked immuno assay (ELISA) from Diagnostic Systems
Laboratory (Webster, TX). Serum interleukin 6 (IL-6)
was determined using the QuantikineW human immuno-
assay kit (R&D Systems Inc., Minneapolis, MN). Serum
estrone-sulfate was determined by radioimmunoassay
using a RIA (radioimmunoassay) assay kit (DSL-5400)
from Beckman Coulter (Fullerton, CA), with a manufac-
turer determined intra-assay precision range of 9.2% for
0.35 ng/mL; 4.6% for 8.89 ngmL; and 4.7% for 59.33 ng/
mL, and, our laboratory determined intra-assay precision
of 6.5% for a concentration of 15 ng/mL. Serum estra-
diol concentration was determined using the Cayman
EIA kit (Cayman Chemical, Ann Arbor, MI) (intra-assay
precision of 15.8% for 41.0 pg/mL; 13% for 102.4 pg/mL;
and 7.1% for 640 pg/mL, and a limit of sensitivity of
6.6 pg/mL(manufacturer-determined)). Serum fatty acid
analysis was performed in serum hexane extracts. Fatty
acids were converted to methyl esters (FAME) according
to the method by Bagga et al. (1997) [32]. FAME were
separated and quantified by use of an Agilent Technolo-
gies (San Diego, CA) 5890A series II gas chromatog-
raphy fitted with a model 7673 automatic split-injection
system and flame ionization detector and SP2380 stabi-
lized phase fused silica capillary column (30 m ×
0.32 mm i.d., 0.25 um film thickness, Supelco, Inc, Belle-
fonte, PA). Quantification was based on the recovery of
a known quantity of the internal standard (tridecanoic
acid, NuChek Preparation Inc., Elysian, MN) and on the
response ratio of fatty acid standards purchased from
NuChek Preparation Inc. (Elysian, MN). For quality con-
trol a pooled serum sample was used.
Estradiol concentration in ductal lavage fluid (DLF)
was determined by gaschromatography mass spectrom-
etry (GC-MS/MS) analysis as described by Zhang et al.
(2006) [33]. 17β-estradiol (Sigma, E-2758), dissolved in
methanol, was used to establish the standard curves.
Deuterated estradiol (17β-estradiol-d3, Sigma #491187)
was added as internal standard to DLF samples prior to
column concentration. Samples were concentrated using
the Supelco Discovery solid phase extraction DPA-6S
columns (Supelco, Bellefonte, PA), pre-bis(trimethylsilyl)
trifluoro-acetamide (BSTFA) with 1% trimethylchlorosi-
lane (TMCS) catalyst (Supelco, Bellefonte PA,#3-3148)
for derivatization at 65°C for 30 min. The derivatized
samples were dried under a nitrogen stream and recon-
stituted with 50 μl hexane. Analyses were carried out
using a ThermoQuest TRACE™ 2000 gas chromatog-
raphy coupled with a ThermoQuest TRACE™ MS. Sam-
ple injection (1 μL) was in splitless mode. The GCcolumn used was a Restek RTx-5 column (15 m ×
0.25 μm× 250 μm). Helium carrier gas was maintained
at a constant flow rate of 1.0mLmin − 1.
Interleukin 6 (IL-6) concentration in breast ductal
fluid was determined using the QuantikineW human im-
munoassay kit (R&D Systems Inc., Minneapolis, MN).
Description of the interventions
Dietary intervention
During the intervention period, patients were asked to
consume only prepared meals distributed by the UCLA
General Clinical Research Center (GCRC). Diets were
comprised of 7 servings of fruits and vegetables, 20% fat,
30% protein, 50% carbohydrates, and 25–35 grams of
fiber per day. Suggested caloric intake to achieve weight
loss was based on a 500-calorie deficit of the partici-
pants’ basal metabolic rate (BMR) as determined by their
BIA measurement conducted at the start of the study.
BMR is derived from FFM (fat-free mass) using an equa-
tion by Grande et al. [34]. Base caloric level was estab-
lished at 1200 calories per day.
Supplemental snacks, in addition to the three meal-
per-day 1200 calorie regimen, tailored the intervention
to each subjects’ BMR. All study subjects in the pilot
diet and exercise intervention required snacks to supple-
ment the 1200 calorie per day regimen, which suggested
to us that the 1200 calorie baseline was a reasonable
starting level to meet caloric requirements in the context
of undergoing exercise training. Food was picked up
from the GCRC by Center for Human Nutrition staff
and distributed to study subjects twice per week. All par-
ticipants received individual consultation on their re-
spective diet plans with a registered dietitian throughout
the study. Every four weeks (week 4 and week 8) sub-
jects were weighed, and blood pressure and BMR
measured.
Exercise intervention
Exercise training was custom-tailored to each woman’s
strength and cardiovascular fitness. Participants began at
an aerobic intensity that was 50% of their maximum
oxygen uptake (VO2Max) determined from the VMax
testing. We translated the VO2Max value into MET
(metabolic equivalent of energy expenditure) units so
that the corresponding intensity level for aerobic exer-
cise could be determined [30]. Aerobic exercise occurred
on treadmills and stationary bicycles. Weight training,
beginning at 50% of the 1-repetition maximum (1-RM)
recorded during muscular testing, was conducted using
standard gym-based weight machines and free weights.
Weight machines used in 1-RM testing were all available
in the gym and were utilized along with supplemental
free weights. At four week intervals, participants
received updated exercises designed to increase their
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their 1-RM so that levels increased to 60%, 70% and 80%
of their maximum values respectively.
Each participant met with the same exercise trainer
for instruction using aerobic and weight resistance
equipment at the designated exercise-training facility at
UCLA, Fit Center South, for at least three times a week,
for a minimum of one-hour sessions. Fit Center South
was open 7 days a week during customary gym hours
and was within close walking distance to the Center for
Human Nutrition. On-site UCLA staff monitored sub-
jects who use the exercise equipment. Notebooks con-
tained each subject’s exercise routine. Subjects recorded
their effort during their exercise intervention. Partici-
pants’ gym cards were scanned to validate attendance.
Statistical analysis
Data were summarized with means and standard devia-
tions calculated for continuous variables and frequencies
for categorical variables using SAS 9.2 (Cary, NC). We
computed percentage change relative to baseline and
95% confidence intervals for all exercise performance,
body composition, and biomarker variables. Change in
strength was summarized by averaging the 1-Rep Max-
imum values derived from the various Kaiser weight
machines used for testing, and computing percentage
change from baseline. Means are expressed with ±
standard deviation (S.D.).
Results
The seven women who participated in the study aver-
aged 55 years old (55.3 ± 5.5 S.D.). Six were Caucasian
with one Asian participant. Women weighed on average
89.8 kg ± 15.3 (197.9 pounds) at baseline. Participants
were moderately obese, (average BMI of 33.6 kg/m2 ±
5.3), and had ‘low’ cardiovascular fitness [35,36] based
on their VO2 Max measurements (13.8 ± 3.7) at baseline
(see Table 1).Table 1 Mean body composition and exercise performance at
Baseline
Variable Mean S.D.
Weight (kg) 89.8 15.3
Body Mass Index (kg/m2) 33.6 5.3
Fat Mass (kg)2 41.3 11.9
Lean Mass (kg)2 43.7 5.6
VO2 Maximum (ml/kg/min)
3 13.8 3.7
1-REP Maximum (lbs)4,5 103.5 25.7
1 post intervention measurements occurred during the 12th intervention week.
2 measured by DEXA (dual-energy x-ray absorptiometry).
3 measured by VMax EncoreW.
4 1 repetition Maximum.
5 1-REP Maximum was averaged over all the muscle groups tested.We observed body composition and exercise perform-
ance improvements at the 12th intervention week com-
pared to baseline. All subjects experienced reductions in
BMI (average 11% reduction from baseline) and fat mass
(14% reduction). Two subjects gained muscle mass, while
the remaining five lost muscle mass, with an average
overall muscle mass loss of 5%. Exercise performance
improved from baseline. Average VO2Max increased by
36% and strength increased by 26%.
Estradiol and IL-6 were measured in ductal fluid at
baseline and at the 12th week (see Table 2). Estradiol
decreased 24% (from 10.5 ± 5.7 nmol/g protein to 8.1 ±
4.3 nmol/g protein) compared to baseline, while IL-6
changed 20% from baseline (0.5 ± 0.4 pg/mL to 0.4 ±
0.3 pg/mL).
We evaluated serum fatty acids, leptin, estrone-sulfate,
estradiol, and IL-6 at baseline and at the 12th week of
the intervention, while subjects were still undergoing the
dietary and exercise regimen (see Table 3). We observed
a 36% decline in serum leptin from baseline (dropping
from 56.1 ± 26.4 ng/mL to 27.2 ± 20.1 ng/mL). Estradiol
also decreased (24%) from baseline (157.9 ± 49.7 pmol/L
dropped to 101.6 ± 27.9 pmol/L). Estrone-sulfate and IL-
6 experienced declines from baseline (estrone sulfate
dropped 10% from 5.8 ± 1.8 to 4.9 ± 2.8, and IL-6
dropped 33% from 2.3 ± 3.0 to 1.6 ± 2.7). Serum fatty
acids were evaluated at the 12th week of the interven-
tion while study subjects were still consuming the con-
trolled dietary regimen. Total polyunsaturated fats
increased slightly (5%) while total saturated fats
decreased (5%) at the 12th week compared to baseline.
Discussion
The pilot study represents the first time hormone and
cytokine biomarkers were measured in ductal fluid be-
fore and after a 12-week controlled dietary and exercise
intervention. We observed reductions in estradiol and
IL-6 levels contained in breast ductal fluid resultingbaseline and post intervention1
Post intervention Percent change
From baseline
Mean S. D. Mean 95% CI
80.3 12.2 −10.3 (−12.6, -8.0)
29.8 3.8 −11.0 (−13.9, -8.1)
35.5 10.9 −14.4 (−18.5, -10.3)
41.4 6.5 −5.4 (−11.1, 0.26)
19.0 6.3 36.1 (21.7, 50.5)
130.3 36.8 25.9 (12.0, 39.8)
Table 2 Hormones, cytokines, and inflammatory factors contained in ductal fluid at baseline and post intervention1
Baseline Post intervention Percent change
From baseline
Variable Mean S.D. Mean S. D. Mean 95% CI
Estradiol (nmol/g protein) 10.5 5.7 8.1 4.3 −23.9 (−113.1, -10.5)
IL-6 (pg/mL) 0.5 0.4 0.4 0.3 −20.0 (−104.2, 72.2)
1 post intervention measurements occurred during the 12th intervention week.
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of changes to the breast environment as a function of
the intervention.
Obese and sedentary women that lived in close prox-
imity to UCLA were interested in the dietary and exer-
cise intervention designed to promote breast cancer
prevention as evidenced by their response to the web-
based Love/Avon Army of Women invitation. We
observed weight loss, fat mass loss, aerobic fitness and
strength increases, and minimal muscle loss among our
participants resulting from the intervention. The loss of
muscle mass that we observed was consistent with other
studies that included calorie restriction and exercise
[37,38]. Ductal fluid sampling and measurement of hor-
mones and cytokines contained within the fluid were
both feasible.
Our intervention consisted of aerobic and resistance
exercise in addition to calorie restriction. We could
therefore not determine whether the fat mass loss and
reduction in serum and ductal fluid estradiol occurred
because of calorie restriction or exercise or both. Evi-
dence from studies of premenopausal women suggest
that both energy balance and nutritional status influence
reproductive hormone levels [39]. We suspect that the
fat mass loss, which occurred as a result of the interven-
tion, was principally responsible for the reductions in
serum and ductal fluid estradiol. However the caloric re-
striction and exercise could have also functioned to re-
duce estradiol independent of fat mass loss.
Several methods for localized breast sampling have
been studied in the literature [40-43]. Sex steroid hor-
mones in breast adipocytes were successfully measuredTable 3 Mean serum hormones, cytokines, and fatty acids at
Baseline
Variable Mean S.D
Leptin (ng/mL) 56.1 26.
Estrone-Sulfate (nmol/L) 5.8 1.
Estradiol (pmol/L) 157.9 49.
IL-6 (pg/ml) 2.3 3.
Total Polyunsaturated Fats (% of total fats) 43.9 6.
Total Saturated Fats (% of total fats) 33.6 2.
1 post intervention measurements occurred during the 12th intervention week.in a small sample of 20 women undergoing breast clin-
ical procedures [41]. While this procedure measured es-
tradiol in digested adipose cells, it was unclear whether
the breast fat estradiol reflected estradiol inside the
breast ducts, although the evidence was suggestive. Nip-
ple aspirate fluid (NAF) has been used in large cohort
studies to assess risk by evaluating presence of NAF, cel-
lularity of NAF, and whether atypical cells are present
[42]. Postmenopausal women, in particular however,
have lower yields of NAF than premenopausal women
[43], and NAF sampling as a technique for collecting
ductal fluid may not be possible for all postmenopausal
women. We chose lavage because we could collect
ductal fluid from non-NAF-fluid producing women [43],
and because ductal fluid has been demonstrated to con-
tain hormones, cytokines, and inflammatory factors in
previous studies [26-28,44]. In our pilot study, three out
of seven participants did not produce aspirate fluid when
we conducted NAF before ductal lavage.
We preliminarily observed a reduction in estradiol
contained in serum and breast ductal fluid suggesting
that the fat mass loss may have promoted a reduction in
aromatization to estradiol. In addition, the changes we
observed systemically and locally suggest that the breast
may be the recipient of two sources of estradiol. Chatterton
et al. (2010) examined patterns of serum steroid hor-
mone level in premenopausal women compared to
nipple aspirate hormone level in both pre- and post-
menopausal women [44]. Whether the source of NAF
estrogen was a result of biosynthesis from local
androstenedione precursors or an enhanced rate of
diffusion into the breast from blood could not bebaseline and post intervention1
Post intervention Percent change
From baseline
. Mean S. D. Mean 95% CI
4 27.2 20.1 −35.5 (−76.1, -25.5)
8 4.9 2.8 −9.9 (−54.2, 34.3)
7 101.6 27.9 −24.4 (−65.7, 17.0)
0 1.6 2.7 −33.0 (−83.3, 8.3)
1 45.5 2.3 5.3 (−7.3, 17.9)
5 31.6 1.1 −5.4 (−13.1, - 2.2)
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conjecture that postmenopausal women could poten-
tially derive estrogen from two sources: adipose tissue
aromatization occurring throughout the body, diffusing
into the blood from the fat tissue, and transported to the
breast; and, additionally, local diffusion of estrogen into
the ducts from breast fat. Identifying the sources of es-
trogen to the breast will require a great deal of future
research.
We observed in our pilot feasibility study a reduction
in ductal fluid IL-6 and a reduction in serum IL-6. IL-6
present in ductal lavage fluid could reflect local inflam-
mation at the breast [1,27] or systemic inflammation
known to be linked to excess abdominal obesity [16].
The pattern of change we observed in IL-6 could be
linked to the fat mass loss, particularly in the serum, but
determining the source of IL-6 change was not possible.
Our results are preliminary and derived from a small
sample that did not have controls. We established feasi-
bility for conducting the diet and exercise intervention
as well as demonstrating the capability to collect ductal
samples and measure hormones and cytokines. The
results are suggestive but not definitive.
Conclusion
In summary, as a result of the pilot 12-week diet and ex-
ercise weight-loss intervention conducted among obese
postmenopausal women, we observed systemic and loca-
lized reductions in serum and ductal fluid estradiol, and
serum and ductal fluid IL-6.
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